Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptima Health Regulatory News (OPT)

Share Price Information for Optima Health (OPT)

Share Price is delayed by 15 minutes
Get Live Data
191.00    0.00 (0.00%)
Bid:
190.00
Ask:
192.00
Spread: 2.00 (1.053%)
Market Cap: £207.76m
OPT Live PriceLast checked at - London Stock Exchange

Intraday Optima Health Share Chart

Full Year Trading Update

17 Apr 2026 07:00

RNS Number : 9162A
Optima Health PLC
17 April 2026
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

17 April 2026

Optima Health plc

("Optima", the "Company", and, together with its subsidiaries, the "Group")

Full Year Trading Update

Full year adjusted EBITDA expected to be c.10% ahead of market expectations

Optima Health (AIM: OPT), the UK's leading provider of technology enabled corporate health and wellbeing solutions, today announces an unaudited trading update for the year ended 31 March 2026.

Further to the previously communicated commentary on current trading announced on 31 March 2026, Optima now expects FY26 Adjusted EBITDA to be ahead of market expectations[1] by c.10%.

Optima has continued to make strong progress against its strategic objectives and medium-term targets of £200 million revenue and £40 million adjusted EBITDA. The recent acquisition of PAM, which completed on 26 March 2026, positions the enlarged Group to capitalise on the growing market opportunity, whilst benefiting from significant operational and cost synergies which will help Optima achieve its medium-term EBITDA target.

The previously disclosed procurement matter has now been settled. Other operating income of £2.3 million was recognised in H1 FY26, and a further £2.4 million has been recognised in H2 FY26.

A full trading update will be made later in Q2 2026.

Jonathan Thomas, Chief Executive Officer, said: "Optima's strong financial performance in H2, ahead of market expectations, reflects the consistent progress we have continued to make against our strategic objectives. The recent transformational acquisition of PAM has further solidified Optima's position in the attractive and growing occupational health market. We look forward to increasing our presence in our core markets, alongside seeking new opportunities, as we continue to accelerate growth."

 

Enquiries

Optima Health

Jonathan Thomas, CEO

Heidi Giles, CFO

 

+44(0)3300085113

media@OptimaHealth.co.uk

Panmure Liberum Limited

Nominated Adviser and Corporate Broker

Emma Earl / Will Goode/ Mark Rogers

Rupert Dearden

 

+44 (0)20 3100 2000

 

Cavendish Capital Markets

Joint Broker

Geoff Nash/Ben Jeynes/George Lawson

Julian Morse/Michael Johnson/Nigel Birks

 

+ 44 (0)20 7220 0500

ICR Healthcare

UK Financial PR Adviser

Mary-Jane Elliott / Angela Gray / Lindsey Neville

optimahealth@icrinc.com

 

 

About Optima Health

Optima Health is the UK's leading provider of occupational health and wellbeing services, delivering clinically led, technology-driven solutions to organisations across the public and private sectors. With a team of more than 2,000 including 1,250 clinicians, Optima Health supports millions of employees and operates from a network of more than 50 clinics nationwide.

 In addition to its core UK market, Optima Health also operates in Ireland under Optima Health Ireland, providing occupational health services to clients nationwide.

 

For more information visit www.optimahealth.co.uk

 


[1] FY26 adjusted EBITDA market consensus £18.1 million

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUBVVRNRUSARR
Date   Source Headline
1st Nov 20067:01 amRNSAnnual Report and Accounts
2nd Oct 20067:02 amRNSMarketing Agreement
31st Jul 20067:02 amRNSAward of Contract in Spain
24th Jul 20067:01 amRNSApplication for Project
19th Jul 200610:04 amRNSUS Senate Speech
23rd Mar 20067:01 amRNSDirectorate Change
8th Mar 20065:50 pmRNSNominated Advisor and Broker
2nd Feb 20067:00 amRNSOPT: First UK project
1st Feb 20067:00 amRNSGrant of Options
30th Jan 20067:00 amRNSInterim Results
30th Jan 20067:00 amRNSContract - Homeland Security
27th Jan 20068:00 amRNSOPT hires engineering head
1st Dec 200511:24 amRNSDirector's Dealing
14th Nov 20057:00 amRNSPowerBuoys deployed
2nd Nov 200510:09 amRNSDirector's Dealing
28th Oct 20057:00 amRNSAnnual Report and Accounts
17th Oct 20057:00 amRNSPreliminary Results
5th Oct 20057:00 amRNSAdditional Listing of Shares
3rd Oct 20057:01 amRNSFurther Funding for Contract
23rd Sep 20059:31 amRNSNotice of Results
9th Aug 20057:00 amRNSUS Energy Bill
8th Aug 20057:00 amRNSAdditional Listing of Shares
22nd Jul 20055:14 pmRNSGrant of Options
22nd Jul 20055:08 pmRNSDirector's Dealing
20th Jun 20059:00 amRNSJoint Venture Agreement
6th May 20054:17 pmRNSAdditional Listing
22nd Apr 200510:58 amRNSDirector's Dealing
8th Feb 20059:12 amRNSAdditional Listing of Shares
25th Jan 20057:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.